New eye scan could spot early signs of wet AMD returning

NCT ID NCT03803631

Completed Knowledge-focused Sponsor: Centre Hospitalier Intercommunal Creteil Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a new, non-invasive eye scan called OCT angiography to see if it can better detect changes in abnormal blood vessels in people with wet age-related macular degeneration (AMD) who are being treated with Eylea. Researchers followed 49 patients to compare the new scan with standard imaging. The goal was to find early signs that the disease might be coming back, which could help doctors adjust treatment sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors detect early signs of wet AMD recurrence using a non-invasive imaging test, potentially improving treatment timing.
What could go wrong: This is a small, completed observational study (49 participants) that does not test a new treatment. The findings may not change current practice without larger validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMD EXUDATIVE MACULAR DEGENERATION

Contacts and locations

Locations

CHI de Créteil

Créteil, 94000, France
Centre Ophtalmologique d'Imagerie et de Laser,

Paris, 75015, France
Hôpital La Croix Rousse

Lyon, 69004, France
Hôpital Lariboisière, APHP

Paris, 75010, France
Hôpital Pellegrin, CHU de Bordeaux

Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.